Ghrelin protects rats against traumatic brain injury and hemorrhagic shock through upregulation of UCP2

Annals of Surgery

Volumn 260, Issue 1, 2014, Pages 169-178

  Qi, Lei ^a,b,c   Cui, Xiaoxuan ^a,b   Dong, Weifeng ^a,b   Barrera, Rafael ^a   Coppa, Gene F ^a   Wang, Ping ^a,b   Wu, Rongqian ^a,b,d  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

ghrelin; hemorrhage; traumatic brain injury; UCP2

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLOID PRECURSOR PROTEIN; ASPARTATE AMINOTRANSFERASE; GENIPIN; GHRELIN; LACTIC ACID; NEUROPROTECTIVE AGENT; UNCOUPLING PROTEIN 2;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN HISTOLOGY; FUNCTIONAL DISEASE; HEMORRHAGIC SHOCK; IMMUNOHISTOCHEMISTRY; LACTATE BLOOD LEVEL; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRAUMATIC BRAIN INJURY; UPREGULATION; VAGOTOMY; VAGUS NERVE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN INJURIES; DISEASE MODELS, ANIMAL; GHRELIN; IMMUNOHISTOCHEMISTRY; ION CHANNELS; MALE; MITOCHONDRIAL PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC; UP-REGULATION;

EID: 84902248954     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000328     Document Type: Article

References (63)

1. Aarabi B, Simard JM. Traumatic brain injury. Curr Opin Crit Care. 2009;15:548-553.
2. Marmarou A, Lu J, Butcher I, et al. IMPACT database of traumatic brain injury: design and description. J Neurotrauma. 2007;24:239-250.
3. Margulies S, Hicks R. Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma. 2009;26:925-939.
4. Maas AI, Marmarou A, Murray GD, et al. Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J Neurotrauma. 2007;24:232-238.
5. Bales JW, Wagner AK, Kline AE, et al. Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis. Neurosci Biobehav Rev. 2009;33:981-1003.
6. Manley G, Knudson MM, Morabito D, et al. Hypotension, hypoxia, and head injury: frequency, duration, and consequences. Arch Surg. 2001;136:1118-1123.
7. Dewitt DS, Prough DS. Blast-induced brain injury and posttraumatic hypotension and hypoxemia. J Neurotrauma. 2009;26:877-887.
8. McHugh GS, Engel DC, Butcher I, et al. Prognostic value of secondary insults in traumatic brain injury: results from the IMPACT study. J Neurotrauma. 2007;24:287-293.
9. Cooper DJ, Myles PS, McDermott FT, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA. 2004;291:1350-1357.
10. Coates BM, Vavilala MS, Mack CD, et al. Influence of definition and location of hypotension on outcome following severe pediatric traumatic brain injury. Crit Care Med. 2005;33:2645-2650.
11. Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993;34:216-222.
12. Pietropaoli JA, Rogers FB, Shackford SR, et al. The deleterious effects of intraoperative hypotension on outcome in patients with severe head injuries. J Trauma. 1992;33:403-407.
13. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660.
14. Wu R, Dong W, Ji Y, et al. Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion. PLoS One. 2008;3:e2026.
15. Wu R, Dong W, Cui X, et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg. 2007;245:480-486.
16. Wu R, Zhou M, Das P, et al. Ghrelin inhibits sympathetic nervous activity in sepsis. Am J Physiol Endocrinol Metab. 2007;293:E1697-E1702.
17. Wu R, Dong W, Zhou M, et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med. 2007;176:805-813.
18. Miao Y, Xia Q, Hou Z, et al. Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats. Biochem Biophys Res Commun. 2007;359:795-800.
19. Cheyuo C,Wu R, Zhou M, et al. Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock. 2011;35:258-265.
20. Bansal V, Ryu SY, BlowC, et al. The hormone ghrelin prevents traumatic brain injury induced intestinal dysfunction. J Neurotrauma. 2010;27:2255-2260.
21. Bansal V, Ryu SY, Lopez N, et al. Vagal stimulation modulates inflammation through a ghrelin mediated mechanism in traumatic brain injury. Inflammation. 2012;35:214-220.
22. Sato N, Kanai S, Takano S, et al. Central administration of ghrelin stimulates pancreatic exocrine secretion via the vagus in conscious rats. Jpn J Physiol. 2003;53:443-449.
23. Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. 2002;123:1120-1128.
24. Ardesch JJ, Buschman HP, Wagener-Schimmel LJ, et al. Vagus nerve stimulation for medically refractory epilepsy: a long-term follow-up study. Seizure. 2007;16:579-585.
25. Ay I, Lu J, Ay H, et al. Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia. Neurosci Lett. 2009;459:147-151.
26. Miyamoto O, Pang J, Sumitani K, et al. Mechanisms of the anti-ischemic effect of vagus nerve stimulation in the gerbil hippocampus. Neuroreport. 2003;14:1971-1974.
27. Cioffi F, Senese R, de Lange P, et al. Uncoupling proteins: a complex journey to function discovery. Biofactors. 2009;35:417-428.
28. Bouillaud F. UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing. Biochim Biophys Acta. 2009;1787:377-383.
29. Samudio I, Fiegl M, Andreeff M. Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res. 2009;69:2163-2166.
30. Affourtit C, Brand MD. On the role of uncoupling protein-2 in pancreatic beta cells. Biochim Biophys Acta. 2008;1777:973-979.
31. Mehta SL, Li PA. Neuroprotective role of mitochondrial uncoupling protein 2 in cerebral stroke. J Cereb Blood Flow Metab. 2009;29:1069-1078.
32. Mattiasson G, Shamloo M, Gido G, et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med. 2003;9:1062-1068.
33. Sun Y, Asnicar M, Saha PK, et al. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 2006;3:379-386.
34. Barazzoni R, Bosutti A, Stebel M, et al. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab. 2005;288:E228-E235.
35. Tsubone T, Masaki T, Katsuragi I, et al. Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regul Pept. 2005;130:97-103.
36. Andrews ZB, Liu ZW, Walllingford N, et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature. 2008;454: 846-851.
37. Marmarou A, Foda MA, van den BW, et al.Anewmodel of diffuse brain injury in rats. Part I: pathophysiology and biomechanics. J Neurosurg. 1994;80:291-300.
38. Foda MA, Marmarou A. A new model of diffuse brain injury in rats. Part II: morphological characterization. J Neurosurg. 1994;80:301-313.
39. Wu R, Dong W, Zhou M, et al. Adrenomedullin and adrenomedullin binding protein-1 prevent metabolic acidosis after uncontrolled hemorrhage in rats. Crit Care Med. 2007;35:912-918.
40. Wu R, Dong W, Zhou M, et al. Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1. Cardiovasc Res. 2005;68: 318-326.
41. Wu R, Zhou M, Dong W, et al. Ghrelin hyporesponsiveness contributes to age-related hyperinflammation in septic shock. Ann Surg. 2009;250:126-133.
42. Medana IM, Esiri MM. Axonal damage: a key predictor of outcome in human CNS diseases. Brain. 2003;126:515-530.
43. Wang G, Lee HM, Englander E, et al. Ghrelin-not just another stomach hormone. Regul Pept. 2002;105:75-81.
44. Van Der Lely AJ, Tschop M, Heiman ML, et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25:426-457.
45. Hattori N, Saito T, Yagyu T, et al. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab. 2001;86:4284-4291.
46. Sakata I, Yamazaki M, Inoue K, et al. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett. 2003;342:183-186.
47. Papotti M, Ghe C, Cassoni P, et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab. 2000;85:3803-3807.
48. Shuto Y, Shibasaki T, Wada K, et al. Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats. Life Sci. 2001;68:991-996.
49. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.
50. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495-522.
51. Krakau K, Omne-Ponten M, Karlsson T, et al. Metabolism and nutrition in patients with moderate and severe traumatic brain injury: a systematic review. Brain Inj. 2006;20:345-367.
52. Nelson TJ, Wall DB, Stedje-Larsen ET, et al. Predictors of mortality in close proximity blast injuries during Operation Iraqi Freedom. J Am Coll Surg. 2006;202:418-422.
53. Capone AC, Safar P, StezoskiW, et al. Improved outcome with fluid restriction in treatment of uncontrolled hemorrhagic shock. J AmColl Surg. 1995;180:49-56.
54. Kim SH, Stezoski SW, Safar P, et al. Hypothermia andminimal fluid resuscitation increase survival after uncontrolled hemorrhagic shock in rats. J Trauma. 1997;42:213-222.
55. Horimoto M, ResnickMB,Konkin TA, et al. Expression of uncoupling protein- 2 in human colon cancer. Clin Cancer Res. 2004;10:6203-6207.
56. Horimoto M, Fulop P, Derdak Z, et al. Uncoupling protein-2 deficiency promotes oxidant stress and delays liver regeneration in mice. Hepatology. 2004;39:386-392.
57. Blanc J, Alves-Guerra MC, Esposito B, et al. Protective role of uncoupling protein 2 in atherosclerosis. Circulation. 2003;107:388-390.
58. Paradis E, Clavel S, Bouillaud F, et al. Uncoupling protein 2: a novel player in neuroprotection. Trends Mol Med. 2003;9:522-525.
59. Richard D, Clavel S, Huang Q, et al. Uncoupling protein 2 in the brain: distribution and function. Biochem Soc Trans. 2001;29:812-817.
60. Echtay KS, Roussel D, St-Pierre J, et al. Superoxide activates mitochondrial uncoupling proteins. Nature. 2002;415:96-99.
61. Coduras A, Rabasa I, Frank A, et al. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study. J Alzheimers Dis. 2010;19:601-615.
62. Bansal V, Costantini T, Ryu SY, et al. Stimulating the central nervous system to prevent intestinal dysfunction after traumatic brain injury. J Trauma. 2010;68:1059-1064.
63. Lindqvist A, Mei J, Sundler F, et al. Decreased UCP2 mRNA expression in rat stomach following vagotomy: novel role for UCP2 as free radical scavenger in the stomach? Nutr Neurosci. 2004;7:217-222.